When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MLNT - Tetraphase on board with Melinta offer; gives notice to AcelRx
Melinta Therapeutics Inc - Ordinary Shares
The board of Tetraphase Pharmaceuticals (NASDAQ:TTPH) has determined that the recent acquisition offer of up to $39.5M in upfront cash and a potential CVR payout from Melinta Therapeutics (NASDAQ:MLNT) is superior to the previously-agreed-to all-stock deal valued at ~$14.4M from AcelRx Pharmaceuticals (NASDAQ:ACRX).
More news on: Tetraphase Pharmaceuticals, Inc., Melinta Therapeutics, Inc., AcelRx Pharmaceuticals, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move,